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ABSTRACT 
Objective: Asystasia gangetica has long been used in the antiasthmatic medicinal preparations of traditional healers Nigeria of South Africa, in India 
the plant is being used for treating diabetes and microbial infections. The present study was evaluated for antidiabetic activity of A. gangetica flower 
ethanol extract (AGFEE) in streptozotocin induced diabetic rats.  
Methods: Diabetes was induced by 45 mg/kg STZ and after STZ induction; the hyperglycemic rats were treated with the extract orally at the dose 
250 mg/kg body weight daily for 45 d. Antidibetic activity measured by blood glucose, insulin, hemoglobin, glycosylated hemoglobin levels. The 
oxidative stress was measured in liver and kidney by level of antioxidant markers i.e. lipid peroxidation (LPO), superoxide dismutase (SOD), 
glutathioneperoxidase (GPx), catalase (CAT) vitamin C and vitamin E and the lipid profile were also studied. 
Results: The extract produced significant reduction in blood glucose level and increase insulin level as compared with the diabetic rats and also 
reduced total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL) and increased high-density lipoprotein (HDL) levels in STZ-diabetic 
rats. It also significantly obliterated the increase in the levels of GPx, SOD and CAT activities in both liver and kidney. The levels of vitamin C and 
vitamin E were significantly augmented in extract treated diabetic rats in comparison with control group.  
Conclusion: This study concludes that the antidiabetic effect of AGFEE proved the folkloric use for various treatments. Further investigations on 
identification and characterization of the active compounds to carried out. 
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INTRODUCTION 
Diabetes mellitus is a metabolic disorder characterized by 
hyperglycemia with impaired metabolism of carbohydrates, fat and 
proteins due to defects in insulin secretion, insulin action or both 
which may lead to the complications like atherosclerosis, cardiac 
dysfunction, retinopathy, neuropathy, and nephropathy [1, 2]. In 
vivo models provide valuable evidences in understanding the 
pathological mechanisms of diabetes and are useful for the 
screening of drugs for the prevention and treatment of diabetes. STZ 
is a commonly used chemical to generate diabetic animals in the 
laboratory for insulin-dependent diabetes mellitus characterized by 
high fasting blood glucose levels and a drastic reduction in plasma 
insulin concentration [3]. Oxidative stress is a major problem 
observed during diabetes induced by the generation of free radicals. 
The increase in the levels of reactive oxygen species and free 
radicals cause damage in the biological structures and also cause 
microvascular and macrovascular complications, cardiovascular 
diseases, kidney and nerve damage [4]. Several antioxidants of plant 
origin have been evaluated for their antioxidant property to protect 
the biological system against oxidative stress in diabetes. In addition 
plant secondary metabolites such as phenols, flavonoids and 
alkaloids are reported in preventing the formation of reactive 
oxygen induced diseases [5]. 
Medicinal plants have always been an exemplary source of drugs and 
many of the currently available drugs have been derived directly or 
indirectly from them. Asystasia gangetica (L) T. Anderson 
(Acanthaceae) is a fast growing, spreading, perennial herb, plant is 
used in ethnomedicine for the treatment of heart pains, stomach pains, 
rheumatism, while in Nigeria, the leaves are popularly used in the 
treatment of asthma [6]. In India, the plant is being used for 
rheumatism and the sap is applied to swellings [7]. In Tamil Nadu, the 
plant root paste is used for skin allergies [8]. It reported to is use as a 
folk remedy for the treatment of diabetes mellitus in parts of south 
India [9]. Till today no studies reported on the diabetic activity of 
flowers of A. gangetica, therefore in the present study, we evaluated 
antidiabetic activity of AGFEE in streptozotocin induced diabetic rats. 
MATERIALS AND METHODS 
Extraction of plant sample 
The plant sample was collected from surrounding area of Karpagam 
University campus, Coimbatore, Tamil Nadu, India and was 
identified as A. gangetica (L.) T. Anderson (Acanthaceae) by 
Botanical Survey of India, Coimbatore (Voucher specimen number 
BSI/SRC/5/23/2011-12/Tech-667). Flowers were dried at room 
temperature for 2 w and ground into powder. Dry powder (200 g) 
was dissolved in 1000 ml of ethanol and kept in a rotary shaker for 
72 h. The extract was filtered; the filtrate was concentrated in a 
room at 40 °C for 24 h and stored at 4 °C for further use. 
Animals 
Rats weighing (150-200 g) were maintained under standard 
conditions of humidity temperature (28±2ºC) and light (12 h 
light/dark). The animals were housed in polypropylene cages 
(45×24×15 cm) and were handled according to the university and 
institutional legislation, regulated by the ethical committee (Regd. 
No. 739/03/abc/CPCSEA).  
Experimental induction of diabetes 
The male albino Wistar rats weighing (150-200 g) were made 
diabetic by intraperitoneal injections of STZ. The animals were 
allowed to fast for 24 h and were given STZ injection (45 mg/kg bw), 
with freshly prepared aqueous solution of citrate buffer as a vehicle, 
pH 4.5. The control animals received buffer alone. STZ treated 
animals were allowed to drink 5% glucose solution overnight to 
overcome drug induced hypoglycemia. After 72 h of STZ 
administration, the blood glucose range above 250 mg/dl were 
considered as diabetic rats and used for the experiment.  
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Experimental design  
In our previous studies, three different doses (125, 250 and 500 
mg/kg bw)were tested for blood glucose lowering potentiality, among 
the three doses at the dose of 250 mg/kg bw the AGFEE showed 
maximum activity. Hence in this study, we selected 250 mg/kg bw 
dose for antidiabetic study. Animal were randomly divided into five 
groups of six animals each: Group I served as control rats, group II 
consisted of diabetic control rats, group III served as diabetic rats 
treated with AGFEE (250 mg/kg bw), group IV consisted of diabetic 
rats treated glibenclamide (5 mg/kg bw) and group V were normal 
rats treated with AGFEE alone (250 mg/kg bw). 
Biochemical studies 
After the treatment of 45 d, the animals were deprived of food 
overnight and sacrificed by cervical decapitation for biochemical 
parameters i.e. hemoglobin [10], urea [11] uric acid [12] total 
protein [13] creatinine [14] HDL [15] triglycerides [16] total 
cholesterol [17]. The liver and kidney were carefully removed, 
weighed and washed in ice-cold saline to remove the blood. Then 
both were sliced separately into pieces and homogenized with buffer 
containing 0.25 M sucrose and 0.1M Tris HCl buffer (pH7.4). The 
homogenate was centrifuged at 3000 ×g for 10 min at 0 °C in a cold 
centrifuge. The supernatant was separated and used for enzymatic 
antioxidant like superoxide dismutase [18], catalase [19], 
glutathione peroxidase [20], and non-enzymatic antioxidants like 
total reduced glutathione [21], vitamin C [22] and vitamin E [23], 
and also used for the determination of lipid peroxidation [24]. 
Histopathological study 
One portion of pancreas of all the experimental groups was fixed in 
10% formalin for histological observation by using the method of 
Dunn 1974 [25] 
Statistical analysis 
All quantitative measurements were expressed as mean±SD for 
control and experimental animals. The data were analyzed using one 
way analysis of variance (ANOVA) followed by Duncan’s Multiple 
Range Test (DMRT) by using statistical package of social science 
(SPSS) version 10.0 for Windows. A difference in the mean values of 
P<0.05 was considered to be statistically significant. 
RESULTS AND DISCUSSION 
Diabetes mellitus is a common and very prevalent disease affecting 
the citizens of both developed and developing countries. It is 
estimated that 25% of the world population is affected by this 
disease. Diabetes mellitus is caused by the abnormality of 
carbohydrate metabolism which is linked to low blood insulin level 
or insensitivity of target organs to insulin. Currently, the use of 
alternative medicines especially consumption of phytochemicals 
have been rapidly increasing worldwide. As herbal medicines are 
less damaging than synthetic drugs they have better compatibility 
thus improving patient tolerance even on long-term use [26, 27]. 
The current study was carried out to determine the antidiabetic 
activity of A. gangetica flowers in STZ induced diabetic rats. STZ has 
been extensively used to induce diabetes mellitus in experimental 
rat models. In the present study at the dose of 45 mg/kg bw induced 
diabetes and produced a significant increase in plasma glucose level 
above 250 mg/dL by selectively destroying the pancreatic insulin 
secreting β cells. STZ produced significant (p<0.05) elevation in 
blood glucose levels of diabetic rats as compared to normal rats 
during the study (fig. 1). In our previous studies, we evaluated blood 
glucose lowering potentiality using three different doses (125, 250 
and 500 mg/kg bw) of AGFEE, At the dose of 250 mg/kg bw the 
extract showed significant activity [28]. Hence, we selected this 
particular dose for this present study. After administration of extract 
at a dose of 250 mg/kg to diabetic rats significant (p<0.05) 
decreased level of blood glucose was observed. The significant 
reduction was evident from the second week onwards, the 
maximum decrease of blood glucose was observed on 5th week after 
administration of extract. Fig. 2 shows the body weight of control 
and experimental rats before and after administration of extract. 
Streptozotocin induced diabetic animals those are treated with 
extract at the dose of 250 mg/kg significantly (p<0.05) increased the 
body weight whereas diabetic control continued to lose weight till 
the end of the study. 
 
 
Fig. 1: Effect of AGFEE on glucose levels of control and 
experimental rate 
Values are expressed as mean±SD (n=6). Values that have a 
different superscript letter (a-e) differ significantly with each 
other at P<0.05 (Duncan’s multiple range test) 
 
 
Fig. 2: Effect of AGFEE on body weight of control and 
experimental rate 
Values are expressed as mean±SD (n=6). Values that have a 
different superscript letter (a-e) differ significantly with each 
other at P<0.05 (Duncan’s multiple range test) 
 
STZ-induced diabetes is characterized by a severe loss in body 
weight due to increased muscle wasting [29]. The decrease in body 
weight is due to the increased muscle destruction or degradation of 
structural proteins [30] When diabetic rats were treated with 
extract hey showed an improvement in body weight in comparison 
to the diabetic control group, which signifies its protective effect in 
controlling muscle wasting and the ability to protect body weight 
loss seems to be the result of its ability to reduce hyperglycemia. 
Table 1 represents the effect of the extract on insulin, hemoglobin 
and glycosylated hemoglobin in normal and STZ induced diabetic 
rats. Administration of extract at the dose of 250 mg/kg bw caused 
significant (p<0.05) increase in insulin and hemoglobin level and 
decrease in glycosylated hemoglobin level. There were no significant 
differences observed in extract alone treated rats compared to 
normal control rats. A significant increase in serum urea, uric acid 
and creatinine levels and a significant decrease in plasma total 
protein levels were observed in diabetic rats whereas treatment 
with extract for 45 d produced reduced serum urea and creatinine 
level and increased total protein when compared to those of diabetic 
groups (table 1). 
Serum TC, TG and LDL were significantly (p<0.05) higher and levels 
of HDL were lower in STZ-induced diabetic rats than those in normal 
Control rats (table 1). Treatment with extract and glibenclamide 
resulted in a significant decrease (p<0.05) in TC, TG and LDL and 
increase HDL levels compared to those in STZ-induced diabetic rats 
(table 1). 
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Table 1: Effect of AGFEE on biochemical parameters in normal and experimental rats 
Parameters Group I Group II Group III Group IV Group V 
Insulin (µU/ml) 16.58±0.75 4.26±0.65d 15.42±0.53a 13.21±0.72c 16.64±0.42b d 
Hb (g/dl) 13.52±0.82 8.47±0.16d 12.81±0.70a 12.60±0.25c 13.39±1.21b 
HbA1c (%) 
d 
5.36±0.32 12.89±0.13d 5.64±0.56a 5.57±0.54c 5.28±0.33b 
Urea mg/dl 
d 
28.24±0.82 64.29±0.29a 32.37±0.14c 31.78±0.57b 28.50±0.42b 
Uric acid 
a 
5.47±0.52 12.80±0.28a 6.75±0.72c 7.63±0.22b 5.75±0.58b 
Total protein/dl 
a 
6.88±0.84 4.25±0.52a 6.35±0.16c 6.22±0.88b 6.75±0.40b 
Crearinine/dl 
a 
0.855±0.34 1.327±0.21a 0.904±0.44c 0.962±0.28b 0.882±0.26b 
HDL 
a 
32.48±6.2 17.36±1.22c 26.71±3.44a 25.63±2.89b 4.48±2.46b 
Triglycerides 
c 














Values are expressed as mean±SD (n=6). Values that have a different superscript letter (a-d) differ significantly with each other at P<0.05 (Duncan’s 
multiple range test). 
 
In the present study, the decreased level of total hemoglobin in 
diabetic rats is mainly due to the increased formation of HbA1c. 
During diabetes mellitus, the excess glucose present in the blood 
reacts with hemoglobin to form HbA1c. The amount of 
HbA1cincrease is directly proportional to the fasting blood glucose 
level [31]. Administration of extract to diabetic rats reduced the 
glycosylation of hemoglobin by virtue of its normoglycaemic activity 
and thus increases the levels of hemoglobin in diabetic rats.  
Urea, uric acid and creatinine in the serum, which are considered 
significant markers of renal function [32], were significantly 
reverted to normal levels after treatment with extract and 
glibenclamide for 45 d. The decreased levels which indicate that the 
extract prevented the progression of renal damage in diabetic rats. 
The concentration of lipids, such as Triglycerides, Total cholesterol 
was significantly increased, whereas HDL cholesterol was decreased 
in the diabetic rats than normal rats. Apart from hyperglycemia, 
diabetes mellitus is accompanied by hypercholesterolemia, 
hyperlipidemia and hepatic steatosis [33] The hypercholesterolemia 
is a consequence of accelerated fatty acid oxidation to acetyl CoA 
which is the primary substrate for cholesterol synthesis [34]. 
Treatment with extract produced a significant reduction in elevated 
triglycerides, total cholesterol and significant (p<0.05) increase in 
(high density lipoprotein) HDL levels within 45 d in diabetic rats. 
The impairment of insulin secretion results in enhanced metabolism 
of lipids from the adipose tissue to the plasma. A variety of 
derangements in metabolic and regulatory mechanisms, due to 
insulin deficiency, are responsible for the observed accumulation of 
lipids [35]. Further, it has been reported previously that diabetic 
rats treated with insulin show normalized lipid levels [36]. Diabetic 
rats treated with extract and glibenclamide also normalized lipid 
levels which indicate that extract also may possess insulin like 
action by virtue of the ability to lower the lipid levels. 
The effects of extract on the levels of serum lipid profile in 
experimental diabetic rats are given in table 1. In diabetic control 
rats, a significant increase in levels of cholesterol, triglycerides, LDL 
and decreased level of HDL were observed when compared to 
normal rats.  
The oxidative stress and resultant tissue damage are important 
component in the pathogenesis of diabetic complications. Diabetes is 
associated with increased formation of free radicals and decreases 
in antioxidant potential. The increase in oxygen free radicals in 
diabetes could be due to increase in blood glucose levels, which 
upon autoxidation generate free radicals [37]. Superoxide dismutase 
(SOD), catalase (CAT) and glutathione peroxidase (GPx) are 
enzymatic antioxidants that play a vital role in preventing cells from 
being exposed to oxidative damage. SOD is capable of reducing the 
superoxide radical into hydrogen peroxide (H2O2) and CAT 
catalyzes the reduction of H2O2 
 
and protects the tissues against 
reactive hydroxyl radicals [38]. In diabetes mellitus, high glucose 
can inactivate antioxidant enzymes SOD, CAT and GPx by glycating 
these proteins thus producing induced oxidative stress, which in 
turn, causes lipid peroxidation [39] table 2 reports the activities of 
enzymatic antioxidants i.e. superoxide dismutase (SOD), catalase 
(CAT) and Glutathione peroxidase (GPx) in kidney and liver of 
normal control, diabetic control and diabetic treated rats. 
Administration of extract for 45 d showed significantly (P<0.05) 
improvement in the activities of these enzymes in diabetic rats. 
Table 2: Effect of AGFEE on enzymatic antioxidants in liver and kidney of control and experimental animals 
Groups Liver  Kidney  
 SOD   CAT   GPx   SOD   CAT   GPx  
Group I  4.27±0.23 1.23±.76a 4.12±.43a 3.48±.92a 1.58±.16a 3.86±.10a a 
Group II  2.02±.43 0.530±38e 2.27±.25d 1.65±.28d 0.82±.59e 1.87±.92d 
Group III  
d 
3.89±.08 1.18±.49d 3.80±.13c 3.26±.65b 1.52±.42b 3.72±.76c 
Group IV  
c 
3.65±.48 1.14±.14c 3.52±.18b 2.88±.58b 1.36±.40c 3.56±.63b 
Group V  
b 
4.15±.17 1.24±.72b 4.02±.88a 3.64±.35c 1.57±.83c 3.87±0.82a a 
SOD: 50% inhibition of NBT reduction/min/mg protein for tissues, CAT: μ mole of H2O2
 
 decomposed/min/mg protein, GPx: µg of glutathione 
consumed/min/mg protein, Values are expressed as mean±SD (n=6). Values that have a different superscript letter (a-e) differ significantly with 
each other at P<0.05 (Duncan’s multiple range test). 
In the present study, reduced activity of SOD and CAT were observed 
in the liver and the kidney; this may be due to the deleterious effect of 
the accumulation of superoxide anion radicals and hydrogen peroxide 
[40]. The result clearly shows that extract contains free radical 
scavenging activity which could exert a beneficial action against 
pathological alteration caused by the presence of O2•-and OH•. 
Glutathione peroxidase is a selenium containing enzyme present in 
significant concentrations that detoxifies H2O2 to H2
Reduced glutathione is one of the most abundant non-enzymatic 
antioxidant bio-molecules present in tissues. Its functions are the 
removal of reactive oxygen species and provision of a substrate for 
GPx and glutathione S-transferase (GST) [42]. Vitamin C at high 
doses has been shown to reduce the accumulation of sorbitol in the 
erythrocytes of diabetes and to inhibit the glycosylation of proteins 
[43]. In the present study reduced vitamin C content level has 
improved after treatment with extract. The decreased level of 
vitamin C in diabetic rats may be either due to increased utilization 
O through the 
oxidation of reduced glutathione [41]. 
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as an antioxidant defense against increased reactive oxygen species 
or due to decreased glutathione level since glutathione is required 
for recycling of ascorbic acid. Vitamin C at high doses has been 
shown to reduce the accumulation of sorbitol in the erythrocytes of 
diabetes and to inhibit the glycosylation of proteins [43].  
Non-enzymatic antioxidants (GSH, vitamin C and E) of liver and 
kidney tissue of normal and treated rats are depicted in table 3. 
Activities of non-enzymatic antioxidants of liver and kidney were 
markedly reduced in diabetic group compared with control and 
treated groups. Treatment with extract at the dose of 250 mg/kg bw 
showed a significant (P<0.05) increase in the activities of non-
enzymatic antioxidants. Vitamin E reduces lipid hydroperoxides 
generated during the process of peroxidation and protects cell 
structures against damages. The decreased level of vitamin E found 
in the liver and kidney of diabetic rats as compared with control rats 
could be due to increased oxidative stress, which accompanies the 
decrease in the level of antioxidant and may be related to the cause 
of diabetes mellitus [44, 45]. 
 
Table 3: Effect of AGFEE on non-enzymatic antioxidants in liver and kidney of control and experimental animals 
 Liver (μg/g) Kidney (μg/g) 
Groups GSH Vitamin C Vitamin E GSH Vitamin C Vitamin E 
Group I  9.44±1.08 1.132±0.080a 1.237±0.03a 8.24±0.37a 1.236±.116a 1.108±0.064a a 
Group II  6.28±0.86 0.812±0.021d 0.853±0.10c 4.22±0.42d 0.836±0.04d 0.755±0.085d 
Group III  
e 
9.14±0.44 1.114±.043c 1.187±0.08b 7.92±0.86c 1.122±0.03c 1.117±0.06c 
Group IV  
d 
8.68±0.27 1.117±0.068b 1.165±0.03b 7.58±0.61b 1.104±0.05b 1.065±0.04b 
Group V  
c 
9.47±0.35 1.137±0.052a 1.235±0.04a 8.27±0.45a 1.222±0.07a 1.114±0.09a b 
Values are expressed as mean±SD (n=6). Values that have a different superscript letter (a-e) differ significantly with each other at P<0.05 (Duncan’s 
multiple range test). 
 
 
Fig. 3: Effect of AGFEE on the levels of lipid peroxide in liver and 
kidney of experimental animals 
Values are expressed as mean±SD (n=6). Values that have a 
different superscript letter (a-e) differ significantly with each 
other at P<0.05 (Duncan’s multiple range test) 
 
 
Fig. 4: Histological examination of pancreas of normal and AGFEE 
treated rats, A: Group I (Normal), B: Group II (Diabetic control),C: 
Group III (Diabetic+glibenclamide 5 mg/kg), D: Group IV 
(Diabetic+AGFEE 250 mg/kg), E: Group V (AGFEE 250 mg/kg) 
 
Lipid peroxidation is one of the characteristic features of chronic 
diabetes and lipid peroxidation mediated tissue damage has been 
observed in diabetic conditions [46]. In the present study, the 
increased lipid peroxidation during diabetes may be due to the 
inefficient antioxidant system prevalent in diabetes. The increase in 
lipid peroxidation indicates an increased oxidative stress as a result 
of the excessive generation of free radicals. Administration of extract 
at the dose of 250 mg/kg bw per day for 45 d decreased the lipid 
peroxidation index significantly (fig. 3). 
Histopathological results 
Photomicrographs of pancreas of normal and experimental rats 
are shown in fig. 4. In control animals, a histopathological 
examination shows normal acini with normal cellular population 
in the islets (fig. 4 A). In diabetic control rats extensive damage 
to the islet of Langerhans and reduced dimensions of islets were 
visible (fig. 4 B), administration of extract in diabetic rats 
showed increased number of β cells and size of islets (fig. 4 C). 
Treatment with glibenclamide showed increased number of β 
cells and size of islets in diabetic rats (fig. 4 D). Extract treated in 
normal rats showed normal acini and normal cellular population 
in the islets (fig. 4 E). 
 
 
Fig. 5: Histological examination of liver of normal and AGFEE 
treated rats, A: Group I (Normal), B: Group II (Diabetic 
control), C: Group III (Diabetic+glibenclamide 5 mg/kg), D: 
Group IV (Diabetic+AGFEE 250 mg/kg), E: Group V (AGFEE 
250 mg/kg) 
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Fig. 6: Histological examination of kidney of normal and AGFEE 
treated rats, A: Group I (Normal), B: Group II (Diabetic control), 
C: Group III (Diabetic+glibenclamide 5 mg/kg), D: Group IV 
(Diabetic+AGFEE 250 mg/kg), E: Group V (AGFEE 250 mg/kg) 
 
Fig. 5 shows the photomicrographs of the liver of normal and 
experimental rats. The liver of normal group rat shows (fig. 5 A) 
normal hepatic cells with well-preserved cytoplasm, nucleus, 
nucleolus and central vein. In diabetic control, the rat’s liver section 
shows lobular architecture, but there was also sinusoidal dilation 
and reduced hepatocytes observed (fig. 5 B). Liver section of rats 
treated with extract and glibenclamide maintained lobular 
architecture normal hepatic cells with well-preserved cytoplasm, 
nucleus, nucleolus and central vein (fig. 5 C and D). Liver section of 
extract alone treated rat shows normal hepatic cells with well-
preserved cytoplasm, nucleus, nucleolus and central vein (fig. 5 E). 
Photomicrographs of kidney sections of normal and experimental 
rats were showed in fig. 6. The kidney section of normal rats showed 
well-arranged cells with compact glomerular basement membrane 
(fig. 6 A). The diabetic control rat’s kidney section showed interstitial 
inflammation, sclerosed glomeruli and dilated tubules (fig. 6 B). 
Diabetic treated rats with glibenclamide and extract showed 
restoration of damage in glomeruli and tubules (fig. 6 C and D). The 
kidney section of extract alone treated rats showed well-arranged cells 
with compact glomerular basement membrane (fig. 6 E). 
CONCLUSION 
The present study showed that the supplementation of extract there 
was a significant decrease in plasma glucose level and 
simultaneously an increase in body weight and the insulin levels 
which clarify the antidiabetogenic action of extract. It also showed 
that the decreased blood glucose, increased antioxidant activity, 
hypolipidemic and decreased lipid peroxidation. The 
histopathological study revealed that the treatment with extract 
showed increase in the number of islets and also prevents the 
organs by suppressing the oxidative stress in associated with 
diabetes and increased insulin secretion are due to the insulin 
released from the regenerated β-cells of the pancreas. 
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